Advertisement
U.S. Markets closed

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS)

NSE - NSE Real Time Price. Currency in INR
456.20-31.10 (-6.38%)
At close: 03:30PM IST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
2,099,880
2,087,020
2,367,140
2,175,840
1,879,456
-
Cost of Revenue
801,840
799,770
923,460
892,820
809,340
-
Gross Profit
1,298,040
1,287,250
1,443,680
1,283,020
1,070,116
-
Operating Expense
1,074,780
1,073,210
1,114,220
1,037,570
882,252
-
Operating Income
223,260
214,040
329,460
245,450
187,864
-
Net Non Operating Interest Income Expense
-8,790
-8,140
-4,130
12,610
24,789
-
Pretax Income
268,880
298,690
348,080
266,420
218,723
-
Tax Provision
65,750
74,060
80,870
77,870
48,140
-
Net Income Common Stockholders
203,130
224,630
267,210
188,550
170,583
-
Diluted NI Available to Com Stockholders
203,130
224,630
267,210
188,550
170,583
-
Basic EPS
10.81
8.49
10.20
7.20
6.51
-
Diluted EPS
10.79
8.46
10.20
7.20
6.51
-
Basic Average Shares
26,215
26,458
26,197
26,198
26,198
-
Diluted Average Shares
26,261
26,552
26,197
26,198
26,198
-
Rent Expense Supplemental
-
-
18,310
24,770
22,687
20,653
Total Expenses
1,876,620
1,872,980
2,037,680
1,930,390
1,691,592
-
Net Income from Continuing & Discontinued Operation
203,130
224,630
267,210
188,550
170,583
-
Normalized Income
227,947
224,630
293,764
191,898
168,629
-
Interest Income
-
-
34,280
15,460
29,924
21,680
Interest Expense
8,790
8,140
4,130
2,610
4,275
-
Net Interest Income
-8,790
-8,140
-4,130
12,610
24,789
-
EBIT
277,670
306,830
352,210
269,030
222,998
-
EBITDA
301,090
323,460
364,260
284,290
233,858
-
Reconciled Cost of Revenue
801,840
799,770
923,460
892,820
809,340
-
Reconciled Depreciation
23,420
16,630
12,050
15,260
10,860
-
Net Income from Continuing Operation Net Minority Interest
203,130
224,630
267,210
188,550
170,583
-
Total Unusual Items Excluding Goodwill
-32,850
0
-34,590
-4,730
2,505
-
Total Unusual Items
-32,850
0
-34,590
-4,730
2,505
-
Normalized EBITDA
333,940
323,460
398,850
289,020
231,353
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
-8,033
0
-8,036
-1,382
551.3398
-